PRF1 and hepatocellular carcinoma: These results had been suggested that anti-hepatocellular carcinoma could be achieved by inhibiting the activity of CD96 molecule of NK cells and promoting the secretion of IFN-γ, TNF-α, PRF1, and GZMB from NK cells.